Samsung Bioepis

Kyrgyzstan
Kyzyl-Suu, Issyk-Kul, Kyrgyzstan

Company profile

Samsung Bioepis company profile

Samsung Bioepis Co., Ltd. develops and produces biopharmaceutical and biosimilar products. Samsung Bioepis Co., Ltd. has a strategic collaboration agreement with Takeda Pharmaceutical Company Limited. The company was incorporated in 2012 and is based in Incheon,

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$100M-$1B
Founded
2012-01-01, Year

Headquarters

Country code
KG
Continent
Asia

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
1
Total equity funding
$667.5M
Last funding
Series Unknown / $667.5M / 2018-06-28
Last equity funding
Series Unknown / $667.5M
Investors
1
Lead investors
1
Articles
315
Exited on
2022-01-27

Founders and investors

Lead investors

Biogen

Investors

Biogen